Insider · CIK 0001448914

Heffernan Michael Thomas

Reports to the SEC for 11 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001448914

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	TRVITrevi Therapeutics, Inc.S Sale	Director	SSale	−18.3K sh	$15.09	−$276K	6,451
2026-09-15	TRVITrevi Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.88	−$1,588	6,351
2026-09-15	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.4K sh	—	—	0
2026-09-15	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.4K sh	$3.04	+$56K	24,772
2026-09-15	TRVITrevi Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+21.1K sh	$3.33	+$70.1K	27,403
2026-09-15	TRVITrevi Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$15.88	−$1,588	6,351
2026-09-15	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.1K sh	—	—	0
2026-09-15	TRVITrevi Therapeutics, Inc.S Sale	Director	SSale	−21K sh	$15.09	−$316K	6,451
2026-06-16	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,000
2026-06-03	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2026-06-02	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2026-04-28	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Director	AAward	+68.7K sh	—	—	68,693
2025-07-08	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-17	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2025-06-11	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-05-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Director	AAward	+31.7K sh	—	—	31,716
2025-03-25	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+4,820 sh	—	—	50,328
2024-06-13	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-05-16	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+7,693 sh	—	—	45,508
2024-04-30	BHVNBiohaven Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	16,592
2023-06-28	TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-22	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-05-18	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,792 sh	—	—	37,815
2023-05-02	BHVNBiohaven Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+52.9K sh	—	—	52,906
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−3,820 sh	—	—	0
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−16K sh	—	—	3,820
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−3,820 sh	$24.16	−$92.3K	28,023
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+3,820 sh	$16.15	+$61.7K	31,843
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−16K sh	$23.63	−$378K	28,023
2022-12-27	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+16K sh	$16.15	+$258K	44,018
2022-12-23	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−4,989 sh	—	—	19,815
2022-12-23	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−4,989 sh	$23.00	−$115K	28,023
2022-12-23	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+4,989 sh	$16.15	+$80.6K	33,012
2022-12-22	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−237 sh	—	—	24,804
2022-12-22	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−237 sh	$23.00	−$5,451	28,023
2022-12-22	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+237 sh	$16.15	+$3,827.55	28,260
2022-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−46.6K sh	$23.11	−$1.08M	28,023
2022-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+46.6K sh	$16.15	+$753K	74,623
2022-12-21	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−46.6K sh	—	—	25,041
2022-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+33.8K sh	$16.15	+$545K	61,781
2022-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−33.8K sh	—	—	71,641
2022-12-20	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−33.8K sh	$23.08	−$779K	28,023
2022-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+3,606 sh	$16.15	+$58.2K	31,629
2022-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−3,606 sh	—	—	105,399
2022-12-19	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−3,606 sh	$23.04	−$83.1K	28,023
2022-12-13	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−162K sh	$22.16	−$3.58M	28,023
2022-12-13	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+7,904 sh	$14.57	+$115K	189,710
2022-12-13	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+94.3K sh	$15.27	+$1.44M	181,806
2022-12-13	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+59.5K sh	$14.90	+$887K	87,547

Recent filings

Accepted (ET)
Sep 174
Heffernan Michael Thomas0001193125-26-394456
SEC(opens sec.gov)
Jun 174
Heffernan Michael Thomas0000929638-26-002258
SEC(opens sec.gov)
Jun 44
Heffernan Michael Thomas0001448914-26-000004
SEC(opens sec.gov)
Jun 44
Heffernan Michael Thomas0001193125-26-257366
SEC(opens sec.gov)
Apr 304
Heffernan Michael Thomas0001448914-26-000002
SEC(opens sec.gov)
Jul 104
Heffernan Michael Thomas0000929638-25-002557
SEC(opens sec.gov)
Jun 184
Heffernan Michael Thomas0001578563-25-000320
SEC(opens sec.gov)
Jun 134
Heffernan Michael Thomas0000950170-25-086111
SEC(opens sec.gov)
May 74
Heffernan Michael Thomas0001935979-25-000046
SEC(opens sec.gov)
Mar 264
Heffernan Michael Thomas0001578563-25-000193
SEC(opens sec.gov)
Feb 124
Heffernan Michael Thomas0001062993-25-002181
SEC(opens sec.gov)
Jun 144
Heffernan Michael Thomas0000950170-24-073727
SEC(opens sec.gov)
May 164
Heffernan Michael Thomas0001062993-24-010537
SEC(opens sec.gov)

Companies

Address

C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR

NEW HAVEN, CT, 06510